Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners

ACS Chemical Biology

Volumn 7, Issue 7, 2012, Pages 1221-1231

  Pollock, Julie A ^a   Larrea, Michelle D ^b   Jasper, Jeff S ^b   McDonnell, Donald P ^b   McCafferty, Dewey G ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HISTONE DEMETHYLASE; LYSINE SPECIFIC DEMETHYLASE 1; SMALL INTERFERING RNA; TRANYLCYPROMINE; TRANYLCYPROMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CONTROL; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; ESTROGEN RECEPTOR ALPHA; FEMALE; HISTONE DEMETHYLASES; HUMANS; PARGYLINE;

EID: 84864127389     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300108c     Document Type: Article

References (43)

1. Cosman, F. and Lindsay, R. (1999) Selective estrogen receptor modulators: clinical spectrum Endocr. Rev. 20, 418-434
2. Siegel, R., Ward, E., Brawley, O., and Jemal, A. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths Ca-Cancer J. Clin. 61, 212-236
3. Strahl, B. D. and Allis, C. D. (2000) The language of covalent histone modifications Nature 403, 41-45
4. Schreiber, S. L. and Bernstein, B. E. (2002) Signaling network model of chromatin Cell 111, 771-778
5. Kelly, W. K., OßConnor, O. A., and Marks, P. A. (2002) Histone deacetylase inhibitors: from target to clinical trials Expert Opin. Invest. Drugs 11, 1695-1713
6. Tan, J., Cang, S., Ma, Y., Petrillo, R. L., and Liu, D. (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents J. Hematol. Oncol. 3, 5-17
7. Bannister, A. J. and Kouzarides, T. (2004) Histone methylation: recognizing the methyl mark Methods Enzymol. 376, 269-288
8. Bannister, A. J. and Kouzarides, T. (2005) Reversing histone methylation Nature 436, 1103-1106
9. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., and Casero, R. A. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119, 941-953
10. Klose, R. J., Yamane, K., Bae, Y., Zhang, D., Erdjument-Bromage, H., Tempst, P., Wong, J., and Zhang, Y. (2006) The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36 Nature 442, 312-316
11. Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C., and Mattevi, A. (2009) A novel mammalian flavin-dependent histone demethylase J. Biol. Chem. 284, 17775-17782
12. Wang, J., Scully, K., Zhu, X., Cai, L., Zhang, J., Prefontaine, G. G., Krones, A., Ohgi, K. A., Zhu, P., Garcia-Bassets, I., Liu, F., Taylor, H., Lozach, J., Jayes, F. L., Korach, K. S., Glass, C. K., Fu, X. D., and Rosenfeld, M. G. (2007) Opposing LSD1 complexes function in developmental gene activation and repression programmes Nature 446, 882-887
13. Hu, Q., Kwon, Y. S., Nunez, E., Cardamone, M. D., Hutt, K. R., Ohgi, K. A., Garcia-Bassets, I., Rose, D. W., Glass, C. K., Rosenfeld, M. G., and Fu, X. D. (2008) Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules Proc. Natl. Acad. Sci. U.S.A. 105, 19199-19204
14. Shi, Y. J., Matson, C., Lan, F., Iwase, S., Baba, T., and Shi, Y. (2005) Regulation of LSD1 histone demethylase activity by its associated factors Mol. Cell 19, 857-864
15. Huang, J., Sengupta, R., Espejo, A. B., Lee, M. G., Dorsey, J. A., Richter, M., Opravil, S., Shiekhattar, R., Bedford, M. T., Jenuwein, T., and Berger, S. L. (2007) p53 is regulated by the lysine demethylase LSD1 Nature 449, 105-108
16. Metzger, E., Wissmann, M., Yin, N., Muller, J. M., Schneider, R., Peters, A. H., Gunther, T., Buettner, R., and Schule, R. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 437, 436-439
17. Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G., Gaudet, F., Li, E., and Chen, T. (2009) The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation Nat. Genet. 41, 125-129
18. Garcia-Bassets, I., Kwon, Y. S., Telese, F., Prefontaine, G. G., Hutt, K. R., Cheng, C. S., Ju, B. G., Ohgi, K. A., Wang, J., Escoubet-Lozach, L., Rose, D. W., Glass, C. K., Fu, X. D., and Rosenfeld, M. G. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors Cell 128, 505-518
19. Lim, S., Janzer, A., Becker, A., Zimmer, A., Schule, R., Buettner, R., and Kirfel, J. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Carcinogenesis 31, 512-520
20. Yang, Z., Jiang, J., Stewart, D. M., Qi, S., Yamane, K., Li, J., Zhang, Y., and Wong, J. (2010) AOF1 is a histone H3K4 demethylase possessingdemethylase activity-independent repression function Cell Res. 20, 276-287
21. Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., and Casero, R. A., Jr. (2007) Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes Proc. Natl. Acad. Sci. U.S.A. 104, 8023-8028
22. Huang, Y., Stewart, T. M., Wu, Y., Baylin, S. B., Marton, L. J., Perkins, B., Jones, R. J., Woster, P. M., and Casero, R. A., Jr. (2009) Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes Clin. Cancer Res. 15, 7217-7228
23. Zhu, Q., Huang, Y., Marton, L. J., Woster, P. M., Davidson, N. E., and Casero, R. A., Jr. (2012) Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells Amino Acids 42, 887-898
24. Schmidt, D. M. and McCafferty, D. G. (2007) trans-2- Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1 Biochemistry 46, 4408-4416
25. Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., and Shiekhattar, R. (2006) Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications Chem. Biol. 13, 563-567
26. Mimasu, S., Sengoku, T., Fukuzawa, S., Umehara, T., and Yokoyama, S. (2008) Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A Biochem. Biophys. Res. Commun. 366, 15-22
27. Mimasu, S., Umezawa, N., Sato, S., Higuchi, T., Umehara, T., and Yokoyama, S. (2010) Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 Biochemistry 49, 6494-6503
28. Yang, M., Culhane, J. C., Szewczuk, L. M., Jalili, P., Ball, H. L., Machius, M., Cole, P. A., and Yu, H. (2007) Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2- phenylcyclopropylamine Biochemistry 46, 8058-8065
29. Gooden, D. M., Schmidt, D. M., Pollock, J. A., Kabadi, A. M., and McCafferty, D. G. (2008) Facile synthesis of substituted trans-2- arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B Bioorg. Med. Chem. Lett. 18, 3047-3051
30. Binda, C., Valente, S., Romanenghi, M., Pilotto, S., Cirilli, R., Karytinos, A., Ciossani, G., Botrugno, O. A., Forneris, F., Tardugno, M., Edmondson, D. E., Minucci, S., Mattevi, A., and Mai, A. (2010) Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2 J. Am. Chem. Soc. 132, 6827-6833
31. Culhane, J. C., Wang, D., Yen, P. M., and Cole, P. A. (2010) Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors J. Am. Chem. Soc. 132, 3164-3176
32. Benelkebir, H., Hodgkinson, C., Duriez, P. J., Hayden, A. L., Bulleid, R. A., Crabb, S. J., Packham, G., and Ganesan, A. (2011) Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors Bioorg. Med. Chem. 19, 3709-3716
33. Scoumanne, A. and Chen, X. (2007) The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners J. Biol. Chem. 282, 15471-15475
34. Huang, Y., Vasilatos, S. N., Boric, L., Shaw, P. G., and Davidson, N. E. (2012) Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells Breast Cancer Res. Treat. 131, 777-789
35. Liang, Y., Vogel, J. L., Narayanan, A., Peng, H., and Kristie, T. M. (2009) Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency Nat. Med. 15, 1312-1317
36. Hoeflich, K. P., OßBrien, C., Boyd, Z., Cavet, G., Guerrero, S., Jung, K., Januario, T., Savage, H., Punnoose, E., Truong, T., Zhou, W., Berry, L., Murray, L., Amler, L., Belvin, M., Friedman, L. S., and Lackner, M. R. (2009) In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models Clin. Cancer Res. 15, 4649-4664
37. Ivshina, A. V., George, J., Senko, O., Mow, B., Putti, T. C., Smeds, J., Lindahl, T., Pawitan, Y., Hall, P., Nordgren, H., Wong, J. E., Liu, E. T., Bergh, J., Kuznetsov, V. A., and Miller, L. D. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res. 66, 10292-10301
38. Frasor, J., Danes, J. M., Komm, B., Chang, K. C., Lyttle, C. R., and Katzenellenbogen, B. S. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology 144, 4562-4574
39. Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H., and Cohen, D. (1999) Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects J. Biol. Chem. 274, 34940-34947
40. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., Sawitzki, G., Smith, C., Smyth, G., Tierney, L., Yang, J. Y., and Zhang, J. (2004) Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5, R80
41. R Development Core Team (2011) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria.
42. Warnes, G. R., Bolker, B., Bonebakker, L., Gentleman, R., Huber, W., Liaw, A., Lumley, T., Maechler, M., Magnusson, A., Moeller, S., Schwartz, M., and Venables, B. (2010) gplots: Various R Programming Tools for Plotting Data, 2.8.0 ed., p R. package.
43. Gaweska, H., Henderson Pozzi, M., Schmidt, D. M., McCafferty, D. G., and Fitzpatrick, P. F. (2009) Use of pH and kinetic isotope effects to establish chemistry as rate-limiting in oxidation of a peptide substrate by LSD1 Biochemistry 48, 5440-5445